Streetbeat News

Analyst Ratings

AIRG

Craig-Hallum analyst Anthony Stoss maintains a 'Buy' rating on Airgain (NASDAQ:AIRG) but lowers the price target from $8 to $6.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 11, 2023 | 1:20 pm

TWLO

Argus Research analyst Jim Kelleher has upgraded Twilio (NYSE:TWLO) from Hold to Buy and set a price target of $72.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 1:19 pm

RIVN

Exane BNP Paribas analyst James Picariello has upgraded Rivian Automotive (NASDAQ:RIVN) from Neutral to Outperform and set a price target of $30.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 1:19 pm

YETI

Morgan Stanley analyst Kimberly Greenberger has maintained an Equal-Weight rating on YETI Holdings (NYSE:YETI) and raised the price target from $47 to $50.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 1:18 pm

SEAT

Deutsche Bank analyst Benjamin Black has maintained a 'Hold' rating on Vivid Seats (NASDAQ:SEAT) and lowered the price target from $10 to $9.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 11, 2023 | 1:18 pm

RGTI

Benchmark analyst David Williams has upgraded Rigetti Computing (NASDAQ:RGTI) from Hold to Buy and set a price target of $4.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 1:17 pm

THRD

Morgan Stanley analyst Michael Ulz maintains an Equal-Weight rating on Third Harmonic Bio (NASDAQ:THRD) and raises the price target from $5 to $7.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 1:16 pm

HUBB

Wolfe Research analyst Nigel Coe has upgraded Hubbell (NYSE:HUBB) from Underperform to Peer Perform.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 1:16 pm

ACCO

HNI

MMM

Three industrial stocks with over 3% dividend yields have been highlighted by Wall Street's most accurate analysts. These include 3M Company (MMM) with a dividend yield of 5.78%, ACCO Brands Corporation (ACCO) with a yield of 5.19%, and HNI Corporation (HNI) with a yield of 3.94%. All three companies have recently reported better-than-expected Q2 results.

Portfolio Pulse from Lisa Levin

August 11, 2023 | 1:15 pm

SBRA

B of A Securities analyst Joshua Dennerlein has upgraded Sabra Health Care REIT (NASDAQ:SBRA) from Underperform to Neutral and raised the price target from $11 to $14.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 1:15 pm